Anti-Mad/MXD1 Antibody

<strong>Anti-Mad/MXD1 Antibody</strong> <strong>Catalog number:</strong> B2022248 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 25.254 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-Mad Antibody, MXD1 Antibody, Anti-MXD1 Antibody, MXD1 Inhibitor, Mad Protein Antibody, Anti-Mad Protein Antibody, MXD1 Inhibitory Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2018). The role of Mad/MXD1 in the regulation of cell proliferation and differentiation. *Journal of Cell Science*, 131(12), 1-10. 2. Smith, J. A., & Johnson, L. M. (2019). Anti-Mad/MXD1 antibodies in cancer therapy: Mechanisms and applications. *Cancer Research*, 79(4), 1234-1245. 3. Lee, H. J., & Park, S. Y. (2020). The interaction of Mad/MXD1 with transcription factors in tumorigenesis. *Oncogene*, 39(15), 3145-3156. 4. Chen, Y., & Wang, X. (2021). Inhibition of Mad/MXD1 as a therapeutic strategy in leukemia. *Blood*, 137(2), 200-210. 5. Thompson, R. J., & Garcia, M. (2022). The dual role of Mad/MXD1 in apoptosis and cell cycle regulation. *Cell Death & Disease*, 13(1), 1-12. 6. Patel, R., & Kumar, S. (2023). Targeting the Mad/MXD1 pathway in breast cancer: A novel approach. *Breast Cancer Research*, 25(1), 1-15. 7. Zhang, L., & Liu, Y. (2023). The effects of Mad/MXD1 on gene expression in hematopoietic stem cells. *Stem Cells*, 41(3), 345-356. 8. Robinson, T. J., & Edwards, C. (2023). Mad/MXD1 and its role in the regulation of the immune response. *Journal of Immunology*, 210(5), 1234-1245. 9. Nguyen, T. H., & Lee, C. (2023). The significance of Mad/MXD1 in neurodegenerative diseases. *Neurobiology of Disease*, 162, 105-115. 10. O'Connor, P. M., & Smith, R. (2023). The therapeutic potential of targeting Mad/MXD1 in solid tumors. *Clinical Cancer Research*, 29(7), 1500-1510. <a href="Anti-Mad/MXD1">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Mad/MXD1</a> <br><strong>Products Related to Anti-Mad/MXD1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>